Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.
about
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersVariation in diabetes care by age: opportunities for customization of careHealth-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetesThe use of adherence aids by adults with diabetes: a cross-sectional surveyQuality of life after acute myocardial infarction: a comparison of diabetic versus non-diabetic acute myocardial infarction patients in Quebec acute care hospitalsRole of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseRelationship between health services outcomes and social and economic outcomes in workplace injury and disease: data sources and methods.Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study.Diabetes: glycaemic control in type 2.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Quality of life and diabetes.Case-control study of 10 years of comprehensive diabetes careA classification scheme for outcome indicators.The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetesA Contemporary Treatment Approach to Both Diabetes and Depression by Cordyceps sinensis, Rich in Vanadium.Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.Control of postprandial state abnormalities: meeting the challenge of type 2 diabetes?The Prevalence and Correlates of Mental and Emotional Health Among American Indian Adults With Type 2 DiabetesTreatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial.Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study.Health care resource utilization associated with a diabetes center and a general medicine clinicHealthy coping: issues and implications in diabetes education and careDiabetes as a chronic metabolic stressor: causes, consequences and clinical complications.Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study.Impediments to drug development.Patient empowerment: a look back, a look ahead.Enhanced glycemic control with combination therapy for type 2 diabetes in primary care.A meta-analysis of interventions to improve care for chronic illnesses.Health-related quality of life and self-related health in patients with type 2 diabetes: effects of group-based rehabilitation versus individual counsellingImproving health outcomes with better patient understanding and education.Self-management support for insulin therapy in type 2 diabetes.Diabetes control and complications: the role of glycated haemoglobin, 25 years on.Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the ADDITION-Cambridge cohortEffect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial.Epidemiology, costs, consequences, and pathophysiology of type 2 diabetes: an american epidemicFatigue in Type 2 Diabetes: Impact on Quality of Life and Predictors.Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetesThe longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.Relationship between Depression and Treatment Satisfaction among Patients with Type 2 Diabetes.
P2860
Q24658031-71048C88-1759-421D-BB73-9E56592EA86AQ24797542-B34D4493-4EFD-40F4-B286-096A8A147BA1Q24807344-71625F02-0B4D-41DA-99CF-36E552C72938Q25257447-416983BD-8940-4FC3-B9AF-73C1A666238BQ25257680-67D198E5-B075-4E7A-9C2B-AA2ECC58A115Q28083039-33645421-3D74-4D5C-8373-A0DF58A4B530Q30662364-DA343272-2154-4A91-B48D-5DAFF3EFC214Q33356250-64EC7CC1-8310-45B2-9788-E1C774AD7FADQ33446693-D8BD6214-4DE9-493A-96BA-C90651BC3483Q33652884-97E3B541-B8FA-4666-ABA6-E80B8C370D9FQ33707382-3FC27E14-13F4-42E9-8331-C94DEF00F9D0Q33727269-936347FC-6A71-4FE2-B3C4-BAD02EC4FDE6Q33812872-B457DF25-91E3-4793-AD5A-887B95A2A9D0Q33905217-EC385317-B9F7-4693-8550-FEB9E8D1B42AQ33919762-0068D8CB-BE90-4A7C-84FA-50AFE64FDBEAQ33982482-3FFF4B77-B280-43A3-9227-066B8C4BCF66Q34024110-8FAE9D97-342E-435E-8690-48CE278AD997Q34076375-1BAD704E-1447-4BFC-A305-B452C082968BQ34139092-F05A1A8F-8A01-4EFF-8921-96E9A4FB4617Q34718335-22F7270B-8E37-4B76-8E1D-4242C6CCEA3EQ34724821-4D7CEB00-D27D-4751-9E70-9D53446DFEDBQ34740212-972D888D-6BFA-4150-AD30-36B5F5ED32C2Q34967351-8188477A-F0F6-4225-A204-A4CF9976D22AQ35032598-88D08056-424F-4FE9-9E91-EDA04E9234D9Q35069677-F5D1754B-425A-4ED6-8CE6-191AA42A0C34Q35130010-B52C538A-FEE9-4175-B2E5-65AB66FA780EQ35175093-36F18673-710F-4453-86CC-7D6D361FC12CQ35214435-E86BEBBB-07AA-41A9-A078-10FC05522349Q35628405-5D1A444F-0369-49F8-860D-783DD1F9E054Q35652457-D42DBE73-2237-486D-97E1-06389CF47D4CQ35727739-3DB4D3CE-19DF-4B35-A03A-25422204C840Q35750490-1C18EE2B-FC42-47DD-A464-43233A9295B0Q35812833-86E84C9E-9757-4FC3-A297-FF35B6EC3CFEQ35870194-622024B9-BEA6-4014-991A-BE6A68862435Q36047201-784C7FA2-406A-4BD4-92F3-0430D784101CQ36065461-D151E0CC-8DF3-4CBD-849E-1E241A5AB703Q36185618-B0F32FA9-3C9C-4D77-977F-04FE6A0CF804Q36196655-D9E4B99B-9201-47E3-8247-D56FBC4A8869Q36223689-023A7E25-8620-49AD-A121-A92CD76A69CDQ36463667-B7CA1402-8519-4F07-9046-27A430F1AC55
P2860
Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Health economic benefits and q ...... ontrolled, double-blind trial.
@en
Health economic benefits and q ...... ontrolled, double-blind trial.
@nl
type
label
Health economic benefits and q ...... ontrolled, double-blind trial.
@en
Health economic benefits and q ...... ontrolled, double-blind trial.
@nl
prefLabel
Health economic benefits and q ...... ontrolled, double-blind trial.
@en
Health economic benefits and q ...... ontrolled, double-blind trial.
@nl
P921
P356
P1476
Health economic benefits and q ...... ontrolled, double-blind trial.
@en
P2093
D C Simonson
P304
P356
10.1001/JAMA.280.17.1490
P407
P577
1998-11-01T00:00:00Z